A host of companies are competing to bring cancer-detecting blood tests to market.

Colorectal cancer is one of the most common cancers in the world and is also one of the leading causes of cancer deaths. It ...

One analyst called the insurer’s decision a “watershed moment” for liquid biopsy-based cancer screening and for the category ...

A new blood test for colorectal cancer screening is being implemented in Alabama to improve early detection and reduce deaths from the disease.

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced its Shield™ blood test for colorectal cancer screening (CRC) is now covered for eligible UnitedHealth Group ...